Olga Vasiljeva

4.9k total citations · 1 hit paper
50 papers, 3.6k citations indexed

About

Olga Vasiljeva is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Olga Vasiljeva has authored 50 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cancer Research, 22 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Olga Vasiljeva's work include Protease and Inhibitor Mechanisms (28 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Peptidase Inhibition and Analysis (11 papers). Olga Vasiljeva is often cited by papers focused on Protease and Inhibitor Mechanisms (28 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Peptidase Inhibition and Analysis (11 papers). Olga Vasiljeva collaborates with scholars based in Slovenia, Germany and United States. Olga Vasiljeva's co-authors include Boris Turk, Vito Türk, Veronika Stoka, M. Renko, Christoph Peters, Thomas Reinheckel, Tao Sun, Matthew Bogyo, Georgy Mikhaylov and Achim Krüger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Olga Vasiljeva

50 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cysteine cathepsins: From structure, function and regulation to new frontiers

2011 1.0k citations Vito Türk, Veronika Stoka et al. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics profile →

Peers

Countries citing papers authored by Olga Vasiljeva

Since Specialization

Citations

This map shows the geographic impact of Olga Vasiljeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Vasiljeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Vasiljeva more than expected).

Fields of papers citing papers by Olga Vasiljeva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Vasiljeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Vasiljeva. The network helps show where Olga Vasiljeva may publish in the future.

Co-authorship network of co-authors of Olga Vasiljeva

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Vasiljeva. A scholar is included among the top collaborators of Olga Vasiljeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Vasiljeva. Olga Vasiljeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Navigating the Clinical Landscape of Liposomal Therapeutics in Cancer Treatment 2025 ·Pharmaceutics ·(unknown), (unknown), Georgy Mikhaylov, Boris Turk, Olga Vasiljeva	7
2	A New Cathepsin D Targeting Drug Delivery System Based on Immunoliposomes Functionalized with Lipidated Pepstatin A 2023 ·Pharmaceutics ·(unknown), Georgy Mikhaylov, (unknown), Elena A. Goun, Boris Turk, Olga Vasiljeva	4
3	The Role of Cysteine Protease Cathepsins B, H, C, and X/Z in Neurodegenerative Diseases and Cancer 2023 ·International Journal of Molecular Sciences ·Veronika Stoka, Olga Vasiljeva, Hiroshi Nakanishi, Vito Türk	16
4	A Probody T Cell–Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity 2022 ·Cancer Research ·Leila M. Boustany, Sherry L. LaPorte, (unknown), (unknown), (unknown), Joel Shen, (unknown), (unknown), Michael B. Winter, Stephen J. Moore, Mei Li, Linnea Diep, Yuanhui Huang, Shouchun Liu, Olga Vasiljeva, Jim West, Jennifer Richardson, Bryan Irving, Marcia Belvin, W. Michael Kavanaugh	35
5	Theranostic Applications of an Ultra-Sensitive T1 and T2 Magnetic Resonance Contrast Agent Based on Cobalt Ferrite Spinel Nanoparticles 2022 ·Cancers ·Georgy Mikhaylov, (unknown), Miha Butinar, Vito Türk, Boris Turk, S. G. Psakhie, Olga Vasiljeva	5
6	First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti–PD-L1 Probody 2021 ·Clinical Cancer Research ·Laura Kist de Ruijter, (unknown), Danique Giesen, Marjolijn N. Lub‐de Hooge, Iris C. Kok, Adrienne H. Brouwers, Sjoerd G. Elias, Margaret Nguyen, Hong Lu, Jourik A. Gietema, Mathilde Jalving, Derk Jan A. de Groot, Olga Vasiljeva, Elisabeth G.E. de Vries	27
7	Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1–Expressing Tumors Compared to Normal Murine Lymphoid Tissue 2020 ·Clinical Cancer Research ·Danique Giesen, (unknown), Marjolijn N. Lub‐de Hooge, I. Yu. Popova, (unknown), Margaret Nguyen, Olga Vasiljeva, Elisabeth G.E. de Vries, (unknown)	36
8	Monitoring protease activity in biological tissues using antibody prodrugs as sensing probes 2020 ·Scientific Reports ·Olga Vasiljeva, (unknown), Margaret Nguyen, Charles S. Craik, W. Michael Kavanaugh	26
9	Non-invasive in vivo imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin 2017 ·Theranostics ·Lovro Kramer, M. Renko, (unknown), Vito Türk, Markus A. Seeger, Olga Vasiljeva, Markus G. Grütter, Boris Turk	42
10	Selective Targeting of Tumor and Stromal Cells By a Nanocarrier System Displaying Lipidated Cathepsin B Inhibitor 2014 ·Angewandte Chemie International Edition ·Georgy Mikhaylov, (unknown), Norbert Schaschke, (unknown), Matej Vizovišek, Marko Fonovič, Vito Türk, Boris Turk, Olga Vasiljeva	60
11	Selective Targeting of Tumor and Stromal Cells By a Nanocarrier System Displaying Lipidated Cathepsin B Inhibitor 2014 ·Angewandte Chemie ·Georgy Mikhaylov, (unknown), Norbert Schaschke, (unknown), Matej Vizovišek, Marko Fonovič, Vito Türk, Boris Turk, Olga Vasiljeva	6
12	A Role for Stefin B (Cystatin B) in Inflammation and Endotoxemia 2014 ·Journal of Biological Chemistry ·(unknown), (unknown), Miha Butinar, Georgy Mikhaylov, Mateja Manček‐Keber, Veronika Stoka, Olga Vasiljeva, Boris Turk, Sergei A. Grigoryev, Nataša Kopitar‐Jerala	54
13	The proinflammatory cytokines interleukin-1α and tumor necrosis factor α promote the expression and secretion of proteolytically active cathepsin S from human chondrocytes 2012 ·Biological Chemistry ·Dejan Caglič, Urška Repnik, Christopher Jedeszko, Gregor Kosec, (unknown), Maik Kindermann, Olga Vasiljeva, Vito Türk, K. Ulrich Wendt, Bonnie F. Sloane, Mary B. Goldring, Boris Turk	30
14	Cysteine cathepsins: From structure, function and regulation to new frontiers breakdown → 2011 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Vito Türk, Veronika Stoka, Olga Vasiljeva, M. Renko, Tao Sun, Boris Turk	1009
15	Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice 2008 ·Oncogene ·Olga Vasiljeva, M. S. Korovin, Mieczysław Gajda, Harald Brodoefel, (unknown), Achim Krüger, Uta Schurigt, Lisa Sevenich, Boris Turk, Christoph Peters, Thomas Reinheckel	99
16	Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets 2007 ·Current Pharmaceutical Design ·Olga Vasiljeva, Thomas Reinheckel, Christoph Peters, Vito Türk, Boris Turk	364
17	Cell Type-specific Functions of the Lysosomal Protease Cathepsin L in the Heart 2007 ·Journal of Biological Chemistry ·(unknown), Jörg Stypmann, Desmond J. Tobin, (unknown), Christian T. Mayer, Sascha Hagemann, Olga Vasiljeva, Thomas Günther, Roland Schüle, Christoph Peters, Thomas Reinheckel	48
18	Dual contrasting roles of cysteine cathepsins in cancer progression: Apoptosis versus tumour invasion 2007 ·Biochimie ·Olga Vasiljeva, Boris Turk	109
19	Tumor Cell–Derived and Macrophage-Derived Cathepsin B Promotes Progression and Lung Metastasis of Mammary Cancer 2006 ·Cancer Research ·Olga Vasiljeva, Anna Papazoglou, Achim Krüger, Harald Brodoefel, M. S. Korovin, Jan M. Deussing, Nicole H. Augustin, Boye Schnack Nielsen, Kasper Almholt, Matthew Bogyo, Christoph Peters, Thomas Reinheckel	296
20	Activation processing of cathepsin H impairs recognition by its propeptide 2005 ·Biological Chemistry ·Martin Horn, (unknown), Lubomı́r Rulı́šek, (unknown), Olga Vasiljeva, Boris Turk, Tudeviin Gan‐Erdene, Miroslav Baudyš, Michael A. Mares	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact